What is the long-term trend for Axsome Therapeutics's amortization of debt discount premium?

Over 4 years (2021 to 2025), Axsome Therapeutics's amortization of debt discount premium has grown at a 4.9% compound annual growth rate (CAGR), from $1.08M to $1.3M.

Axsome Therapeutics AXSM Amortization Of Debt Discount Premium

Amortization Of Debt Discount Premium at other companies

Extra Space StorageEXR

$1.18M-8.8%

Equity ResidentialEQR

$601K-2.0%

Claros Mortgage TrustCMTG

$569K—

Annaly Capital ManagementNLY

$21.25M+680%

SQSQ

——

NYM

NYMTNYMT

——

Other financials

Income statement

See full

Revenue$191.2M+57.4%

Gross profit$176.5M+58.0%

Operating income-$63.4M-11.2%

Net income-$64.5M-8.6%

EPS (diluted)-$1.26-3.3%

Balance sheet

See full

Cash & equivalents$305.1M+1.4%

Total debt$219.9M+4.1%

Total equity$54.6M+2.6%

Total assets$713.6M+19.6%

Cash flow

See full

Operating cash flow-$20.7M+52.3%

CapEx$121.0K-64.2%

Free cash flow-$20.8M+52.4%

Valuation

See full

Market cap$12.89B+52.0%

Enterprise value$12.81B+52.9%

P/S18.2×-1.4×

Profitability

See full

Gross margin92.6%+1.1pp

Operating margin-24.4%-9.3pp

Net margin-26.6%-9.8pp

FCF margin-10.2%-3.9pp

Returns & leverage

See full

Return on equity-349.4%+109pp

Debt / equity4×+0.1×

Current ratio1.4×-0.6×

Where this comes from

Reported directly by Axsome Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axsome Therapeutics's amortization of debt discount premium.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Axsome Therapeutics's amortization of debt discount premium?: Axsome Therapeutics (AXSM) reported amortization of debt discount premium of $159K in Q1 2026.
How has Axsome Therapeutics's amortization of debt discount premium changed year-over-year?: Axsome Therapeutics's amortization of debt discount premium decreased by 76.2% year-over-year, from $667K to $159K.
What is the long-term trend for Axsome Therapeutics's amortization of debt discount premium?: Over 4 years (2021 to 2025), Axsome Therapeutics's amortization of debt discount premium has grown at a 4.9% compound annual growth rate (CAGR), from $1.08M to $1.3M.